$1.5 million grant supports alternatives to opioids initiative at University Hospitals

A grant of nearly $1.5 million from the Department of Health and Human Services through its Substance Abuse and Mental Health Services Administration (SAMHSA) will enable University Hospitals Cleveland Medical Center to develop and implement an Alternatives to Opioids (ALTO) program within its Emergency Department (ED).

Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care | Psychedelic Invest

NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced the recruitment of Perth, Australia-based

October 24, 2024

Charles River and Wheeler Bio partner on therapeutic discovery

Share this article The integrated offering is aimed at simplifying the management of multiple vendor relationships, connecting preclinical work. Credit: fotohunter/Shutterstock.com. Charles River Laboratories has

February 22, 2024

How does intermittent fasting affect the gut microbiome?

Review examines the effects of intermittent fasting (IF) on the human gut microbiome, revealing variable impacts on microbiota composition and diversity, influenced by fasting type,

February 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.